UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Common Herbal Dietary Supplement-Drug Interactions

American family physician, 2017-07, Vol.96 (2), p.101-107

2017

Volltextzugriff (PDF)

Feedback for Learning in Pharmacy Education: A Scoping Review

Pharmacy, 2021-04, Vol.9 (2), p.91

2021

Volltextzugriff (PDF)

Implementation of targeted interventions to decrease antiretroviral-related errors in hospitalized patients

American journal of health-system pharmacy, 2012-03, Vol.69 (5), p.422-430

2012

Volltextzugriff (PDF)

2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV

Clinical infectious diseases, 2017-11, Vol.65 (10), p.e1-e37

2017

Volltextzugriff (PDF)

Effect of efavirenz on levonorgestrel concentrations among Malawian levonorgestrel implant users for up to 30 months of concomitant use: a subanalysis of a randomized clinical trial

Contraception: X, 2020-01, Vol.2, p.100027, Article 100027

2020

Volltextzugriff (PDF)

Vaginal microbiome, antiretroviral concentrations, and HIV genital shedding in the setting of hormonal contraception initiation in Malawi

AIDS (London), 2023-11, Vol.37 (14), p.2185-2190

2023

Volltextzugriff (PDF)

Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol

Pilot and feasibility studies, 2017-07, Vol.4 (1), p.21-21, Article 21

2017

Volltextzugriff (PDF)

2017 HIV Medicine Association of Infectious Diseases Society of America Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With Human Immunodeficiency Virus

Clinical infectious diseases, 2017-11, Vol.65 (10), p.1601-1606

2017

Volltextzugriff (PDF)

Antiretroviral drug exposure in the female genital tract : implications for oral pre-and post-exposure prophylaxis

AIDS (London), 2007-09, Vol.21 (14), p.1899-1907

2007

Volltextzugriff (PDF)

Kaletra (lopinavir/ritonavir)

The Annals of pharmacotherapy, 2002-07, Vol.36 (7-8), p.1193-1203

2002

Volltextzugriff (PDF)

Endogenous Hormones and Antiretroviral Exposure in Plasma, Cervicovaginal Fluid, and Upper-Layer Packed Cells of Malawian Women Living with HIV

AIDS research and human retroviruses, 2020-08, Vol.36 (8), p.641-646

2020

Volltextzugriff (PDF)

Healthcare Professionals’ Perspectives on Improving Dietary Supplement Documentation in the Electronic Medical Record: Current Challenges and Opportunities to Enhance Quality of Care and Patient Safety

Global advances in integrative medicine and health, 2023-11, Vol.12, p.27536130231215029-27536130231215029

2023

Volltextzugriff (PDF)

Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry

Biomedical chromatography, 2007-10, Vol.21 (10), p.1095-1104

2007

Volltextzugriff (PDF)

Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks post-partum: results of the BAN Study

Antiviral therapy, 2014-01, Vol.19 (6), p.587-595

2014

Volltextzugriff (PDF)

Frequency of HIV-related medication errors and associated risk factors in hospitalized patients

The Annals of pharmacotherapy, 2008-04, Vol.42 (4), p.491-497

2008

Volltextzugriff (PDF)

Dose Separation Does Not Overcome the Pharmacokinetic Interaction between Fosamprenavir and Lopinavir/Ritonavir

Antimicrobial Agents and Chemotherapy, 2006-08, Vol.50 (8), p.2756-2761

2006

Volltextzugriff (PDF)

Antiretroviral pharmacology in breast milk

Advances in experimental medicine and biology, 2012, Vol.743, p.109

Corbett, Amanda H

2012

Volltextzugriff (PDF)

Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians

Pharmacogenomics, 2012-01, Vol.13 (1), p.113-121

2012

Volltextzugriff (PDF)

Guidelines for the use of extended-release nevirapine in HIV-infected patients

Expert opinion on pharmacotherapy, 2011-12, Vol.12 (17), p.2713-2718

2011

Volltextzugriff (PDF)

Self-report of current and prior antiretroviral drug use in comparison to the medical record among HIV-infected patients receiving primary HIV care

Pharmacoepidemiology and drug safety, 2011-04, Vol.20 (4), p.432-439

2011

Volltextzugriff (PDF)

Plasma Bile Acid Concentrations in Patients with Human Immunodeficiency Virus Infection Receiving Protease Inhibitor Therapy: Possible Implications for Hepatotoxicity

Pharmacotherapy, 2010-01, Vol.30 (1), p.17-24

2010

Volltextzugriff (PDF)

Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian adults

AIDS (London), 2007-01, Vol.21 (1), p.59-64

2007

Volltextzugriff (PDF)

Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women

Journal of acquired immune deficiency syndromes (1999), 2004-12, Vol.37 (5), p.1577-1580

2004

Volltextzugriff (PDF)

Pharmacokinetics of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian children

Antiviral therapy, 2010, Vol.15 (1), p.83-90

2010

Volltextzugriff (PDF)

The pharmacokinetics, safety, and initial virologic response of a triple-protease inhibitor salvage regimen containing amprenavir, saquinavir, and ritonavir

Journal of acquired immune deficiency syndromes (1999), 2004-08, Vol.36 (4), p.921-928

2004

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(53)
Buchkapitel
(2)

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Common Herbal Dietary Supplement-Drug Interactions

Feedback for Learning in Pharmacy Education: A Scoping Review

Implementation of targeted interventions to decrease antiretroviral-related errors in hospitalized patients

2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV

Effect of efavirenz on levonorgestrel concentrations among Malawian levonorgestrel implant users for up to 30 months of concomitant use: a subanalysis of a randomized clinical trial

Vaginal microbiome, antiretroviral concentrations, and HIV genital shedding in the setting of hormonal contraception initiation in Malawi

Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol

2017 HIV Medicine Association of Infectious Diseases Society of America Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With Human Immunodeficiency Virus

Antiretroviral drug exposure in the female genital tract : implications for oral pre-and post-exposure prophylaxis

Kaletra (lopinavir/ritonavir)

Endogenous Hormones and Antiretroviral Exposure in Plasma, Cervicovaginal Fluid, and Upper-Layer Packed Cells of Malawian Women Living with HIV

Healthcare Professionals’ Perspectives on Improving Dietary Supplement Documentation in the Electronic Medical Record: Current Challenges and Opportunities to Enhance Quality of Care and Patient Safety

Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry

Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks post-partum: results of the BAN Study

Frequency of HIV-related medication errors and associated risk factors in hospitalized patients

Dose Separation Does Not Overcome the Pharmacokinetic Interaction between Fosamprenavir and Lopinavir/Ritonavir

Antiretroviral pharmacology in breast milk

Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians

Guidelines for the use of extended-release nevirapine in HIV-infected patients

Self-report of current and prior antiretroviral drug use in comparison to the medical record among HIV-infected patients receiving primary HIV care

Plasma Bile Acid Concentrations in Patients with Human Immunodeficiency Virus Infection Receiving Protease Inhibitor Therapy: Possible Implications for Hepatotoxicity

Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian adults

Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women

Pharmacokinetics of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian children

The pharmacokinetics, safety, and initial virologic response of a triple-protease inhibitor salvage regimen containing amprenavir, saquinavir, and ritonavir

Suchergebnisse filtern